76
Views
12
CrossRef citations to date
0
Altmetric
Review

New treatments for myasthenia: a focus on antisense oligonucleotides

, &
Pages 13-17 | Published online: 10 Jan 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Waqar Waheed, Eric Newman, Marwa Aboukhatwa, Maryam Moin & Rup Tandan. (2022) Practical Management for Use of Eculizumab in the Treatment of Severe, Refractory, Non-Thymomatous, AChR + Generalized Myasthenia Gravis: A Systematic Review. Therapeutics and Clinical Risk Management 18, pages 699-719.
Read now

Articles from other publishers (11)

Deepak Menon & Vera Bril. (2022) Pharmacotherapy of Generalized Myasthenia Gravis with Special Emphasis on Newer Biologicals. Drugs 82:8, pages 865-887.
Crossref
Saranya B Gomathy, Ayush Agarwal & Venugopalan Y Vishnu. (2022) Molecular Therapy in Myasthenia Gravis. Neurology 18:1, pages 49.
Crossref
Evelyn Jou-Chen Huang, Meng-Huang Wu, Tsung-Jen Wang, Tsung-Jen Huang, Yan-Rong Li & Ching-Yu Lee. (2022) Myasthenia Gravis: Novel Findings and Perspectives on Traditional to Regenerative Therapeutic Interventions. Aging and disease, pages 0.
Crossref
Swathi Beladakere Ramaswamy, Shivangi Singh, Sara Hooshmand, Cho Junsang, Megan Sweeney & Raghav Govindarajan. (2021) Current and Upcoming Treatment Modalities in Myasthenia Gravis. Journal of Clinical Neuromuscular Disease 23:2, pages 75-99.
Crossref
Pingping Ren, Luying Lu, Shasha Cai, Jianghua Chen, Weiqiang Lin & Fei Han. (2021) Alternative Splicing: A New Cause and Potential Therapeutic Target in Autoimmune Disease. Frontiers in Immunology 12.
Crossref
Deepak Menon, Carolina Barnett & Vera Bril. (2020) Novel Treatments in Myasthenia Gravis. Frontiers in Neurology 11.
Crossref
Zeynep Özdemir & Mehmet Abdullah Alagöz. 2019. Selected Topics in Myasthenia Gravis. Selected Topics in Myasthenia Gravis.
Xiao-Li Li, Heng Li, Min Zhang, Hua Xu, Long-Tao Yue, Xin-Xin Zhang, Shan Wang, Cong-Cong Wang, Yan-Bin Li, Ying-Chun Dou & Rui-Sheng Duan. (2016) Exosomes derived from atorvastatin-modified bone marrow dendritic cells ameliorate experimental autoimmune myasthenia gravis by up-regulated levels of IDO/Treg and partly dependent on FasL/Fas pathway. Journal of Neuroinflammation 13:1.
Crossref
Elena Moroz, Simon Matoori & Jean-Christophe Leroux. (2016) Oral delivery of macromolecular drugs: Where we are after almost 100 years of attempts. Advanced Drug Delivery Reviews 101, pages 108-121.
Crossref
Taylan Peköz, Ahmet Evlice & Filiz Koc. (2015) A Case of Myasthenia Gravis Associated With Kaposi Sarcoma. Neurosurgery Quarterly 25:2, pages 234-235.
Crossref
Nir Waiskopf & Hermona Soreq. 2015. Handbook of Toxicology of Chemical Warfare Agents. Handbook of Toxicology of Chemical Warfare Agents 761 778 .